NHS England and Wales:
Nice recommendations on new tests to rule out pregnancy complication and avoid unnecessary hospital admission.
In a final guidance, a recommendation for 2 blood tests to help rule-out pre-eclampsia, a potentially life threatening complication affecting as many as one in 16 pregnant women1.NICE recommends the Triage PlGF test (Alere) and the Elecsys immunoassay sFlt-1/PlGF ratio (Roche Diagnostics) to help rule-out pre eclampsia in women between their 20th and 35th week of pregnancy.The tests detect changes in blood that can mean the placenta is not developing properly.The testa are only recommended to help rule out pre-eclampsia. They are not recommended to help doctors diagnose pre-eclampsia. The guidance calls for further research on both tests to see if they can be used in future to rule in pre-eclampsia.
Guidance recommends 2 blood tests to help rule out pre-eclampsia, a potentially life threatening complication affecting up to one in 16 pregnant women1.
They recommend the Triage PlGF test (Alere) and the Elecsys immunoassay sFlt-1/PlGF ratio (Roche Diagnostics) to help rule-out pre-eclampsia in women between their 20th and 35th week of pregnancy.
The tests detect changes in blood that can mean the placenta is not developing properly.
The use of the tests are only to help rule-out pre-eclampsia and not recommended to diagnose pre-eclampsia. Further research is required to see if these tests can be used in future to rule in pre-eclampsia.